Connect with TRB at ESCRS 2025 and Discover our Ocular Surface Health Solutions

TRB Chemedica is pleased to announce its participation as an exhibitor at ESCRS 2025, held from 12–16 September at the Bella Center in Copenhagen, Denmark.

The 43rd Congress of the European Society of Cataract and Refractive Surgeons is one of the most influential gatherings in the field of ophthalmology, drawing over 15,000 professionals from around the world. This year’s edition offers a dynamic programme covering the latest advances in cataract and refractive surgery, as well as hands-on learning through live surgeries, instructional courses, and expert-led wet labs.

Beyond the scientific programme, ESCRS 2025 also embraces sustainability and community well-being. Highlights include the BoSS (Best of the Show & Sustainability) track, which focuses on responsible innovation in eye care, and the 5K Charity Run, set against the backdrop of Copenhagen’s Amager Fælled nature reserve.

TRB Chemedica will be present at Booth C4.018, presenting its latest solutions in ocular surface health. Visitors are invited to meet our team and discover how TRB is supporting post-operative comfort and long-term vision health.

Find out more

TRB at ISIAT 2025 in Bucharest – Advancing Joint Health Together

From October 2–4, 2025, we’ll be exhibiting at the 8th International Symposium on Intra‑Articular Treatment (ISIAT), held at the Pullman Bucharest World Trade Center. This biennial congress unites international experts in intra‑articular therapies for musculoskeletal disorders. At Booth E, the #TRBTeam is eager to discuss our products in joint-focused treatments for orthopedics and rheumatology specialties.

The symposium program features dynamic consensus updates from EUROVISCO, GRIIP, ESCEO and other leading guideline groups—including discussions on PRP, viscosupplementation, and orthobiologics in osteoarthritis treatment. Attendees can also join hands‑on ultrasound‑guided injection workshops spanning ankle, knee, hip, shoulder, hand/wrist and facet joints, led by expert faculty to refine technical skills.

Key scientific sessions include:

Comparisons of intra‑articular products, such as adipose‑derived microfragmented fat vs. leukocyte‑poor PRP and hyaluronic acid, and bone‑marrow concentrate (BMAC) vs. adipose‑derived cell suspensions (ADCS) in knee osteoarthritis.
Predictors of treatment response, exploring how patient demographics and disease stage influence outcomes with PRP and HA therapies.
Bio‑toxicity studies examining chondrotoxicity of injection products, updated protocols for orthobiologics, and new emerging injectables.
Athlete‑focused content on intra‑articular interventions for trauma recovery, optimal timing for IA injections in high‑level sport, and functional outcomes research.

These sessions underscore ISIAT’s role as a platform for advancing translational science and driving clinical innovation in musculoskeletal care.

We look forward to connecting with orthopedic surgeons and rheumatologists at Booth E to exchange evidence‑based insights on improving patient outcomes through our latest advances in musculoskeletal treatments.

Find out more

Discover TRB’s Insights at CPHI Europe 2025 in Frankfurt from October 28–30

TRB Chemedica will be attending CPHI Europe 2025 in Frankfurt from October 28–30. This international event connects professionals from every segment of the pharmaceutical value chain.

Visit our booth to discuss our therapeutic focus areas—musculoskeletal disorders and dry eye disease—as well as opportunities in in-licensing, out-licensing, and global distribution.

We invite you to meet our team, explore potential collaborations, share insights, and discover more about our company, portfolio, and worldwide network.

Looking forward to seeing you there!

Learn more

TRB Academy Webinar: Tailoring Injectable Treatments for Tendinopathies

Join us for an insightful webinar hosted by TRB Academy, focusing on musculoskeletal disorders. This event will feature Prof. Anja Hirschmüller, a renowned expert in sports medicine, orthopedics, and traumatology. She will present on the topic: “Tailoring Injectable Treatments for Tendinopathies: From Evidence to Clinical Practice.”

Event Details

– Date and Time: Monday, June 30th, from 6:00 to 7:00 PM (CET)
– Duration: 1 hour
– Location: Webinar hosted live
– Presentation by Prof. Anja Hirschmüller: The session will begin with a presentation by Prof.
– Hirschmüller, followed by a Q&A session with the audience.
– Agenda: Latest scientific insights and practical treatment approaches
– tendinopathies with injectable therapies.
– Registration: Interested participants can register via the Wisembly platform.

Don’t miss this opportunity to increase your knowledge and network with experts in the field. Register now to secure your place and be part of the conversation.

Registration

TRB Chemedica at ISAKOS Congress 2025: Advancing Musculoskeletal Health

Join us at the 15th Biennial ISAKOS Congress in Munich, June 8-11, 2025. This premier international event brings together experts in arthroscopy, knee surgery, and sports medicine.

TRB Chemedica is proud to participate with a booth, showcasing our commitment to musculoskeletal health and patient care.

Visit us at Booth 21 to learn more about our solutions and how they benefit patients.

Find out more

Join TRB Chemedica at ISOKINETIC Madrid: Elevate Your Practice

The Isokinetic Conference 2025 in Madrid is a unique opportunity to connect with global experts in sports medicine. TRB Chemedica is proud to participate, showcasing our expertise in musculoskeletal disease and sports medicine. Visit us at Booth 29-31 to learn how our solutions support better patient outcomes. Experience the excitement at the Atletico de Madrid stadium and get a chance to lift a replica of the Champions League cup.

Find out more

TRB Chemedica Sponsors OARSI 2025: Advancing OA Care

The OARSI World Congress 2025 is the leading event for osteoarthritis research. It will be held from April 24–27 in Incheon, South Korea. TRB Chemedica is proud to sponsor this event, demonstrating our commitment to improving patient outcomes. Join us to learn how our solutions contribute to better care and results.

Learn more about us

Join us at the 25th WCO-IOF-ESCEO Congress in Rome

Mark your calendars, the WCO-IOF-ESCEO Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases is fast approaching.

Join us in Rome from 10 to 13 April 2025 at stand 2 to discuss how we at TRB Chemedica are helping patients affected by these diseases.

This year marks the 25th edition of the WCO-IOF-ESCEO Congress and is once again packed with insightful scientific sessions, symposia and lectures. As osteoarthritis is one of our key therapeutic areas, we will be keeping an eye out for presentations on this topic and would welcome the opportunity to interact with you.

Learn more about us

TRB to Attend XXVI Congresso AICCER 2025 in Trieste

TRB will attend the XXVI Congresso AICCER – ASSOCIAZIONE ITALIANA DI CHIRURGIA DELLA CATARATTA E REFRATTIVA, taking place from March 27–29, 2025, at the Generali Convention Center in Trieste. We look forward to welcoming attendees at our booth (n°19) and sharing our ongoing commitment to innovation in the field of ophthalmology.

Learn more

TRB will be present at the Convention on Pharmaceutical Ingredients (CPHI) in Milano

We are pleased to announce that TRB will be present at the Convention on Pharmaceutical Ingredients, CPHI 2024 in Milano, Italy. This year CPHI is celebrating 35 years of uniting pharma professionals.

You are invited to visit us at booth 14F54 (Hall 14) from October 8 to 10. We look forward to engaging with you and discussing how our products can meet your needs in this ever-evolving industry.

Learn more